Premium
Factors contributing to the efficacy of two add‐on therapies of fesoterodine or mirabegron to silodosin monotherapy for persistent overactive bladder in men with lower urinary tract symptoms
Author(s) -
Matsukawa Yoshihisa,
Gotoh Momokazu
Publication year - 2020
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/iju.14117
Subject(s) - silodosin , medicine , overactive bladder , mirabegron , urology , lower urinary tract symptoms , prostate , alternative medicine , pathology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom